Metabolomics analysis of cervical cancer, cervical intraepithelial neoplasia and chronic cervicitis by 1H NMR spectroscopy

European Journal of Gynaecological Oncology

Volumn 36, Issue 2, 2015, Pages 174-180

  Ye, N ^a   Liu, C ^a   Shi, P ^a  

^a CAPITAL NORMAL UNIVERSITY   (China)

Author keywords

1H NMR spectroscopy; Cervical cancer; Cervical intraepithelial neoplasia; Chronic cervicitis; Metabolomics; PLS DA

Indexed keywords

ACETIC ACID; ALANINE; BIOLOGICAL MARKER; CARNITINE; FORMIC ACID; GLUCOSE; GLUTAMINE; GLYCINE; INOSITOL; ISOLEUCINE; LACTIC ACID; TYROSINE; VALINE; VERY LOW DENSITY LIPOPROTEIN; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; DISCRIMINANT ANALYSIS; FEMALE; HUMAN; MAJOR CLINICAL STUDY; METABOLISM; METABOLITE; METABOLOMICS; MULTIVARIATE ANALYSIS; PROTEIN BLOOD LEVEL; PROTON NUCLEAR MAGNETIC RESONANCE; UTERINE CERVICITIS; UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA IN SITU; BLOOD; CITRIC ACID CYCLE; MIDDLE AGED; PROCEDURES; REGRESSION ANALYSIS; UTERINE CERVIX TUMOR;

ADULT; CERVICAL INTRAEPITHELIAL NEOPLASIA; CHOLESTEROL, VLDL; CITRIC ACID CYCLE; FEMALE; HUMANS; LEAST-SQUARES ANALYSIS; METABOLOMICS; MIDDLE AGED; PROTON MAGNETIC RESONANCE SPECTROSCOPY; UTERINE CERVICAL NEOPLASMS; UTERINE CERVICITIS;

EID: 84929397905     PISSN: 03922936     EISSN: None     Source Type: Journal    
DOI: 10.12892/ejgo2613.2015     Document Type: Article

References (38)

1. Yang B.H., Bray F.I., Parkin D.M., Sellors J.W., Zhang Z.F.: "Cervical cancer as a priority for prevention in different world regions: An evaluation using years of life lost". Int. J. Cancer, 2004, 109, 418.
2. Arbyn M., Castellsague X., de Sanjose S., Bruni L., Saraiya M., Bray F., et al.: "Worldwide burden of cervical cancer in 2008". Ann. Oncol., 2011, 22, 2675.
3. Soeijomataram I., Lortet-Tieulent J., Parkin D.M., Ferlay J., Mathers Forman D., et al.: "Global burden of cancer in 2008: A systematic analysis of disability-adjusted life-years in 12 world regions". Lancet, 2012, 380, 1840. doi: 10.1016/S0140-6736(12) 60919-2.
4. Bray F., Jemal A., Grey N., Ferlay J., Forman D.: "Global cancer transitions according to the human development index (2008-2030): A population-based study". Lancet Oncol., 2012, 13, 790.
5. Chen D., Juko-Pecirep I., Hammer J., Ivansson E., Enroth S., Gustavsson I., et al.: "Genome-wide association study of susceptibility loci for cervical cancer". J. Natl. Cancer Inst., 2013, 105, 624.
6. Schifiman M., Castle P.E.: "Human papillomavirus: epidemiology and public health". Arch. Pathol. Lab. Med., 2003, 127, 930.
7. Kinde I., Bettegowda C., Wang Y.X., Wu J., Agrawal N., Shih I.M., et al.: "Evaluation of DNA from the Papanicolaou test to detect ovarian and endometrial cancers". Sci. Transl. Med., 2013, 5, 167ra4. doi: 10.1126/scitranslmed.3004952.
8. Guo M, Gong Y, Wang JP, Dawlett M, Patel S, Liu P, et al. The role of human papillomavirus type 16/18 genotyping in predicting high- grade cervical/vaginal intraepithelial neoplasm in women with mildly abnormal Papanicolaou results. Cancer Cytopathol., 2013, 121, 2, 79.
9. Abulafia O., Pezzullo J.C., Sherer D.M.: "Performance of thinPrep liquid-based cervical cytology in comparison with conventionally prepared Papanicolaou smears: A quantitative survey". Gynecol. Oncol., 2003, 90, 137.
10. Monsonego J., Autillo-Touati A., Bergeron C., Dachez R., Liaras J., Saurel J., et al.: "Liquid-based cytology for primary cervical cancer screening: A multi-centre study". Brit. J. Cancer, 2001, 84, 360.
11. Doyle B., O'Farrell C., Mahoney E., Turner L., Magee D., Gibbons D: "Liquid-based cytology improves productivity in cervical cytology screening". Cytopathology, 2006, 17, 60.
12. Whynes D.K., Sharp L., Cotton S.C., Cruickshank M., Gray N.M., Little J., et al.: "Impact of alternative management policies on health- related quality of life in women with low-grade abnormal cervical cytology referred for colposcopy". Eur. J. Obstet. Gyn. Reprod Biol., 2013, 169, 88.
13. Monsonego J., Hudgens M.G., Zerat L., Zerat J.C., Syijanen K., Smith J.S.: "Risk assessment and clinical impact of liquid-based cytology, oncogenic human papillomavirus (HPV) DNA and mRNA testing in primary cervical cancer screening (the FASE study)". Gynecol. Oncol., 2012, 125, 175.
14. Sigurdsson K.: "Is a liquid-based cytology more sensitive than a conventional pap smear?" Cytopathology, 2013, 24, 254.
15. Ye N.S., Li J.: "Serum protein profiling of cervical cancer patients using surface-enhanced laser desorption/ionization time-of-flight mass spectrometry". Anal. Lett., 2013, 46, 250.
16. Putri S.P., Nakayama Y., Matsuda F., Uchikata T., Kobayashi S., Matsubara A., et al.: "Current metabolomics: practical applications". J. Biosci. Bioeng., 2013, 115, 579.
17. Monteiro M.S., Carvalho M., Bastos M.L., de Pinho P.G.: "Metabolomics analysis forbiomarker discovery: Advances and challenges". Curr. Med. Chem., 2013, 20, 257.
18. Fan L.J., Zhang W., Ym M.Z., Zhang T., Wu X.Y., Zhang H.Y., et al.: "Identification of metabolic biomarkers to diagnose epithelial ovarian cancer using a UPLC/QTOF/MS platform". Acta Oncol., 2012, 51, 473.
19. Jankevics A., Liepinsh E., Liepinsh E., Vilskersts R., Grinberga S., Pugovics O., et al.: "Metabolomic studies of experimental diabetic urine samples by 'H NMR spectroscopy and LC/MS method". Chemometr. Intell. Lab., 2009, 97, 11.
20. Grivet J.P., Delort A.M., Portais J.C.: "NMR and microbiology: fiom physiology to metabolomics". Biochimie, 2003, 85, 823.
21. Beckonert O., Keun H.C., Ebbels T.M.D., Bundy J.G., Holmes E., Lindon J.C., et al.: "Metabolic profiling, metabolomic and metabo- nomic procedures for NMR spectroscopy of urine, plasma, serum and tissue extracts". Nat. Protoc., 2007, 2, 2692.
22. Emwas A.H.M., Salek R.M., Griffin J.L., Merzaban J.: "NMR-based metabolomics in human disease diagnosis: Applications, limitations, and recommendations". Metabolomics, 2013, 9, 1048. doi: 10.1007/sll306-013-0524-y.
23. Odunsi K., Wollman R.M., Ambrosone C.B., Hutson A., McCann S.E., Tammela J., et al.: "Detection of epithelial ovarian cancer using "H NMR-based metabonomics". Int. J. Cancer, 2005, 113, 782.
24. Tiziani S., Lopes V., Gunther U.L.: "Early stage diagnosis of oral cancer using 'H NMR-based metabolomics". Neoplasia, 2009, 11, 269.
25. Ronco G., Segnan N., Giorgi-Rossi P., Zappa M., Casadei G.P., Carozzi F., et al.: "Human papillomavirus testing and liquid-based cytology: results at recruitment from the new technologies for cervical cancer randomized controlled trial". J. Natl. Cancer Inst., 2006, 98, 765.
26. Ronco G., Cuzick J., Pierotti P., Cariaggi M.P., Dalla Palma P., Naldoni C., et al.: "Accuracy of liquid based versus conventional cytology: overall results of new technologies for cervical cancer screening randomised controlled trial". BMJ, 2007, 335, 28.
27. Lyng H., Sundfor K., Rofstad E.K.: "Changes in tumor oxygen tension during radiotherapy of uterine cervical cancer: relationships to changes in vascular density, cell density, and frequency of mitosis and apoptosis". Int. J. Radiat. Oncol., 2000, 46, 935.
28. Lyng H., Sundfor K., Trope C., Rofstad E.K.: "Disease control of uterine cervical cancer: relationships to tumor oxygen tension, vascular density, cell density, and frequency of mitosis and apoptosis measured before treatment and during radiotherapy". Clin. Cancer Res., 2000, 6, 1104.
29. Mahon M.M., deSouza N.M., Dina R., Soutter W.P., Mclndoe G.A., Williams A.D.et al.: "Preinvasive and invasive cervical cancer: An ex vivo proton magic angle spinning magnetic resonance spectroscopy study". NMR Biomed., 2004, 17, 144.
30. Sitter B., Bathen T., Hagen B., Arentz C., Skjeldestad F.E., Gribbestad I.S.: "Cervical cancer tissue characterized by high-resolution magic angle spinning MR spectroscopy". MAGMA, 2004, 16, 174.
31. Daly P.F., Lyon R.C., Faustino P.J., Cohen J.S.: "Phospholipid metabolism in cancer cells monitored by 31P NMR spectroscopy". J. Biol. Chem., 1987, 262, 14875.
32. Rocha C.M., Carrola J., Banos A.S., Gil A.M., Goodfellow B.J., Carreira I.M., et al.: "Metabolic signatures of lung cancer in biofluids: NMR-based metabonomics of blood plasma". J. Proteome. Res., 2011, 70, 4314.
33. Carrola J., Rocha C.M., Banos A.S., Gil A.M., Goodfellow B.J., Carreira I.M., et al.: "Metabolic signatures of lung cancer in biofluids: NMR-based metabonomics of urine". J. Proteome. Res., 2011, 10, 221.
34. Wei L., Liao P.Q., Wu H.F., Li X.J., Pei F.K., Li W.S., et al.: "Toxi- cological effects of cinnabar in rats by NMR-based metabolic profiling of urine and serum". Toxicol. Appl. Pharm., 2008, 227, 417.
35. Hasim A., Ali M., Mamtimin B., Ma J.Q., Li Q.Z., Abudula A.: "Metabonomic signature analysis of cervical carcinoma and precancerous lesions in women by 'H NMR spectroscopy". Exp. Ther. Med., 2012, 3, 945.
36. Carraro P., Zago T., Plebani M.: "Exploring the initial steps of the testing process: frequency and nature of pre-preanalytic errors". Clin. Chem., 2012, 58, 638.
37. Ym P.Y., Peter A., Franken H., Zhao X.J., Neukamm S.S., Rosenbaum L., et al.: "Preanalytical aspects and sample quality assessment in metabolomics studies of human blood". Clin. Chem., 2013, 59, 833.
38. Leray G., Quemener V., Rumeur E.L., Benoist L., Auvray E., Decertaines J.D.: "Proton NMR spectroscopy of plasma lipoproteins in the experimental Lewis lung carcinoma". Anticancer Res., 1992, 12, 1227.